IOVA
IOVA
US4622601007
Iovance Biotherapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.62B EUR
1.88B EUR
1.54B EUR
1.12B EUR
Enterprise Value
5.78B EUR
1.82B EUR
1.39B EUR
1.01B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-68.16x
--
--
--
Price to Sales
20.38x
5.8x
5.38x
5.25x
Price to Book
9x
2.61x
2.13x
1.61x
EV/Revenue
17.78x
5.6x
4.86x
4.72x
EV/EBITDA
-22.26x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.84%
-15.73%
-19.84%
-20.13%
ende